Search Results

(GPCRs) that control virtually everything in the body as drug targets. GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the biology and for the identification of drug targets and future drug development. She has made numerous important discoveries related to the mechanisms that control PAR1 signaling and discovery and genomic analysis, delivered technical presentations and software demonstrations to prospective

GPCR Ecosystem We unite the GPCR Community to advance drug discovery Where GPCR Experts Move Science Forward Join the global community accelerating GPCR drug discovery through trusted insights, expert tools GPCR began as a podcast. Premium Members Include: ✔ Drug hunters at early-stage biotechs ✔ CRO leaders building assays and tools behind-the-scenes tools and insight What Makes the Ecosystem Different Built for Drug Discovery Designed

GPCR Podcast Strategic Partners Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar This could accelerate discovery of therapeutic targets by combining multiplex data with focused downstream ________ Key Takeaway This episode is more than a conversation — it’s a masterclass in tool-driven discovery , GPCR drug discovery , GPCR online course Summary created by AI ________ About Tom Sakmar Tom Sakmar is a physician-scientist and Rockefeller University professor dedicated to drug discovery and chemical

spatial signaling — a field reshaping how we understand receptor biology and drug discovery. How disease can hijack signaling organization — and what that means for drug discovery. In GPCR drug discovery, where complexity is the rule and timelines are tight, this kind of cross-functional It’s an open vault of knowledge. 🟢 Read More → https://www.ecosystem.drgpcr.com/post/accelerating-gpcr-drug-discovery-what drug discovery. 🎧 Explore how predictive modeling is reshaping GPCR science in this Dr.

targets — a top-down rethink for drug discovery. << Back to podcast list Dr. GPCR Podcast Strategic Partners GPCRs and the Science Behind Pain and Recovery with Dr. “We’re using outdated drugs. There are more elegant GPCR targets waiting to be explored.” He’s fascinated by transgenerational epigenetics — how parental pain, diet, or drug exposure can leave GPCR ecosystem, GPCR drug discovery, GPCR podcast, GPCR data platform, GPCR training program, RGS4, chronic

Applying Pharmacology to Drug Discovery Dr. Terry Kenakin Get Started Premium Members benefits: - Subscribe and save 25% on every GPCR Course - Early-bird access - Recordings will be available < Back to GPCR courses Watch recording Your Instructor Dr.

GPCR Podcast Strategic Partners Empowering Drug Discovery for the GPCR Community with Dr. GPCR Enjoying the Dr. GPCR Podcast? Leave a Review. Review on Apple Podcasts ★ Rate on Spotify ✉️ Send feedback to the team Recent Podcast Articles How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research How GPCR Spatial Signaling Sparked a Scientific Journey Thanks for listening to this podcast episode

Principles of Pharmacology in Drug Discovery II Dr. Terry Kenakin Get Started Premium Members benefits: - Subscribe and save 25% on every GPCR Course - Early-bird access - Recordings will be available < Back to GPCR courses Watch recording Your Instructor Dr.

Principles of Pharmacology in Drug Discovery I Dr. Terry Kenakin Get Started Premium Members benefits: - Subscribe and save 25% on every GPCR Course - Early-bird access - Recordings will be available < Back to GPCR courses Watch recording Your Instructor Dr.

Master irreversible kinetics, target depletion, and structured tissue penetration in real drug discovery Home → Flash News → irreversible drugs post 3 Irreversible kinetics = strategic lever in drug design. strategic levers that shape how molecules behave in vivo and whether candidates advance or stall in discovery These lessons bridge molecular pharmacology with real-world design strategy, giving discovery teams the GPCR Ecosystem #GPCR #DrGPCR #Pharmacology #DrugDiscovery #Kinetics #ReceptorPharmacology #MedicinalChemistry

Discover how low-offset kinetics reshape drug efficacy. Join Terry’s Corner and master irreversible pharmacology for modern discovery programs. Home → Flash News → irreversible drugs post 1 Irreversible Drugs – Trailer Published on October 21, 2025 In modern discovery programs, that’s a decisive advantage (or a hidden liability) in candidate selection GPCR Ecosystem #GPCR #DrGPCR #Pharmacology #DrugDiscovery #MedicinalChemistry #PKPD #ReceptorKinetics

discovery Subscribe to the Dr. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️ https://www.ecosystem.drgpcr.com high-resolution-deep-mutational-scanning-of-the-melanocortin-4-receptor-enables-target-characterization-for-drug-discovery discovery Subscribe to the Dr. high-resolution-deep-mutational-scanning-of-the-melanocortin-4-receptor-enables-target-characterization-for-drug-discovery

Sign up today 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. GPCR Courses 💡 GPCR drug development doesn’t have to be a mystery! Learn from Dr. Sign up today 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism Drug discovery often assumes receptor GPCR Podcast 4 days ago Molecular creativity in drug discovery Most pharmacologists are trained to chase

and lateral gateways, unlocking new possibilities for drug discovery. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️https://www.ecosystem.drgpcr.com #gpcr#drgpcr Published on March 17, 2025 Category GPCR Weekly News A large-scale analysis of GPCR molecular dynamics reveals hidden allosteric sites and lateral gateways, unlocking new possibilities for drug discovery.

Looking to sharpen your skills in GPCR pharmacology, drug discovery, data analysis, or project management science ✅ Practical insights for real-world drug discovery challenges ✅ Flexible, on-demand learning #Biotech #DrGPCR Published on March 11, 2025 Category GPCR Weekly News 🔬 Enhance Your GPCR Expertise Looking to sharpen your skills in GPCR pharmacology, drug discovery, data analysis, or project management science✅ Practical insights for real-world drug discovery challenges✅ Flexible, on-demand learning to

Curious about how these advances could impact drug discovery? Check out the latest review on GPCR biosensors. Curious about how these advances could impact drug discovery? Check out the latest review on GPCR biosensors. ➡️ https:// www.ecosystem.drgpcr.com/reviews/gpcr-biosensors-to-study-conformational-dynamics-and-signaling-in-drug-discovery

🔬🧪 Molecular glues offer a new way to fine-tune receptor signaling, opening doors for next-gen drug discovery Subscribe to the Dr. on February 17, 2025 Category GPCR Weekly News Game-changer for GPCR research! 🔬🧪 Molecular glues offer a new way to fine-tune receptor signaling, opening doors for next-gen drug discovery Subscribe to the Dr.

Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program - A new platform for GPCR antibody drug discovery Abstract Developing monoclonal antibody drugs against GPCRs and other multi-pass transmembrane targets, such as ion channels, remains a significant challenge technology, demonstrated in the success of COVID-19 vaccines, is emerging as a promising method for antibody discovery developing highly specific antibodies for complex targets, with implications for overcoming challenges like drug

Home → Flash News → Behind every great discovery is a great question 🚀 Dr. GPCR podcast episode. If you’re passionate about GPCRs and drug discovery, this episode is a must-listen! GPCR Podcast Behind every great discovery is a great question 🚀 Dr. If you’re passionate about GPCRs and drug discovery, this episode is a must-listen!

Yamina Berchiche 🔒 Premium Content Watch recording Applying Pharmacology to Drug Discovery Class 1 - Discovery II Advanced Methods for the Optimization of Candidate Selection Lecture 1: The Eyes to See GPCR Ligands as Drugs Lecture 5: Unique Exploitable GPCR-Ligand Behaviors for Therapeutic Benefit Terry Kenakin 🔒 Premium Content Watch recording Principles of Pharmacology in Drug Discovery I Techniques for Discovery of New Molecules Lecture 2: Drug Affinity: Measurement of Antagonism (Binding and Function

and drug discovery innovation. << Back to podcast list Dr. drug developer and entrepreneur. discovery. Ajay reveals how humility, curiosity, and collaboration fuel the future of drug discovery. Seeing the limits of traditional drug discovery, he later co-founded Superluminal Medicines, a company

🎉 This is your new go-to for mastering drug discovery pharmacology. Driving drug discovery? Apply pharmacology to selectivity, ADME, and strategic decision-making. 🎉 This is your new go-to for mastering drug discovery pharmacology. Driving drug discovery? Apply pharmacology to selectivity, ADME, and strategic decision-making. GPCR Podcast 4 days ago Molecular creativity in drug discovery Most pharmacologists are trained to chase

Discovery. David has over 20+ years of experience working in a drug discovery environment mainly in a specialist Discovery that he was awarded in 2020. discovery. " Dr. GPCR Enjoying the Dr. GPCR Podcast? Leave a Review.

signaling and drug discovery. Home → Flash News → How GPCR Spatial Signaling Sparked a Scientific Journey How GPCR Spatial Signaling GPCR Podcast When boredom met obsession. spatial signaling — a field reshaping how we understand receptor biology and drug discovery. 🔓 Want deeper GPCR insights?

Gabriele Kockelkoren shares: 🔬 How GPCR spatial organization shapes signaling and drug responses 🌍 the unknown is key to scientific breakthroughs A must-listen for biophysicists, pharmacologists, and drug hunters pushing the boundaries of discovery! Gabriele Kockelkoren shares:🔬 How GPCR spatial organization shapes signaling and drug responses🌍 His hunters pushing the boundaries of discovery!

scientists to study ligand-receptor interactions, visualize binding, and accelerate drug discovery. for scientists to study ligand-receptor interactions, visualize binding, and accelerate drug discovery Next Recent Articles Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism Drug discovery often assumes receptor inhibition follows simple rules—agonist binds, antagonist blocks, and GPCR Podcast 4 days ago Molecular creativity in drug discovery Most pharmacologists are trained to chase

GPCR Podcast Strategic Partners Dr. Brian Arey About this episode Brian Arey is Senior Director of Mechanistic Pharmacology within Leads Discovery Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular He continues to pioneer in drug discovery studying GPCRs and other target classes. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

GPCR Podcast Strategic Partners Dr. Brian Arey About this episode Brian Arey is Senior Director of Mechanistic Pharmacology within Leads Discovery Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular He continues to pioneer in drug discovery studying GPCRs and other target classes. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery stabilization and structure-based drug design. Marshall is the VP Head of Neuroscience Discovery and Head of Discovery UK, Global Head of Neuroscience discovery research leading teams in West Point, Boston, and London at MSD. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

discovery campaigns. I have extensive training in computer-aided drug design. training as a chemist and as an entrepreneur to grow a sustainable service and software provider in drug discovery. GPCR Enjoying the Dr. GPCR Podcast? Leave a Review.